Colesevelam: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}}; {{AE}} {{SS}} | {{CMG}}; {{AE}} {{SS}} | ||
'' | ===''Colesevelam hydrochloride''=== | ||
* [[Welchol]] | |||
==Overview== | ==Overview== | ||
| Line 13: | Line 13: | ||
Bile acid sequestrant | Bile acid sequestrant | ||
{{Lipid modifying agents}} | {{Lipid modifying agents}} | ||
Revision as of 16:52, 26 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Colesevelam hydrochloride
Overview
Colesevelam is a bile acid sequestrant administered orally. It is developed by Genzyme and marketed in the US by Daiichi Sankyo under the brand name Welchol and elsewhere by Genzyme as Cholestagel. In Canada it is marketed by Valeant as Lodalis.
Category
Bile acid sequestrant